SSG
COV

Summit Securities Group’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Summit Securities Group’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,200
Closed -$225K – 766
2014
Q4 		$225K Buy
2,200
+1,700
+340% +$163K 0.06% 179
2014
Q3 		$43K Buy
+500
New +$44.3K 0.01% 417

Summit Securities Group's COV Position: Q1 2015 in Review

Summit Securities Group sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 2,200 shares — an estimated $225K sold.

Summit Securities Group first reported a position in COV in Q3 2014 and held it in 2 quarters. The position peaked at $225K in Q4 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Summit Securities Group reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Summit Securities Group sold 2,200 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $225K.
  • Summit Securities Group first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q3 2014 and held it in 2 quarters.
  • Summit Securities Group's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $225K in Q4 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Summit Securities Group's 13F filing for Q1 2015, filed 22 Apr 2015.